High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines

Journal of Medical Virology

Volumn 81, Issue 3, 2009, Pages 545-551

  Miyashita, Michiko ^a   Agdamag, Dorothy M ^b   Sasagawa, Toshiyuki ^a   Matsushita, Kaori ^a   Salud, Lourdes Ma ^c   Salud, Calixto O ^c   Saikawa, Kunikazu ^a   Leano, Prisca S ^b   Pagcaliwagan, Teresita ^c   Acuna, Jessica ^c   Ishizaki, Azumi ^a   Kageyama, Seiji ^a   Ichimura, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b San Lazaro Hospital   (Philippines)

^c Makati Social Hygiene Clinic   (Philippines)

Author keywords

Cervical cytology; Female commercial sex workers; HPV high risk type; Philippines

Indexed keywords

CALGRANULIN; VIRUS DNA;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GENOTYPE; GONORRHEA; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 52; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; NUCLEOTIDE SEQUENCE; PHILIPPINES; POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS; ADOLESCENT; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PAPILLOMA VIRUS; PATHOLOGY; PREVALENCE; PROSTITUTION; UTERINE CERVIX; VAGINA SMEAR; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADOLESCENT; ADULT; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHILIPPINES; PREVALENCE; PROSTITUTION; SEQUENCE ANALYSIS, DNA; VAGINAL SMEARS;

EID: 60049091299     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21416     Document Type: Article

References (39)

1. Asato T, Maehama T, Nagai Y, Kanazawa K, Uezato H, Kariya K. 2004. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 189:1829-1832.
2. Baseman JG, Koutsky LA. 2005. The epidemiology of human papillomavirus infections. J Clin Virol 32:S16-S24.
3. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802.
4. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. 1999. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 37:3316-3322.
5. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH. 1996. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 23:333-341.
6. Cañadas MP, Bosch FX, Junquera ML, Ejarque M, Font R, Ordoñez E, de Sanjosé S. 2004. Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol 42:1330-1332.
7. Choi BS, Kim O, Park MS, Kim KS, Jeong JK, Lee JS. 2003. Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers. J Med Virol 71:440-445.
8. Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E. 2002. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902-907.
9. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062.
10. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459.
11. del Amo J, González C, Losana J, Clavo P, Muñoz L, Ballesteros J, García-Saiz A, Belza MJ, Ortiz M, Menéndez B, del Romero J, Bolumar F. 2005. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 81:79-84.
12. Frain K, Grac DM, William AF. 2006. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150.
13. Fujimori K, Okada T, Urade Y. 2002. Expression of NADP+-dependent 15-hydroxyprostaglandin dehydrogenase mRNA in monkey ocular tissues and characterization of its recombinant enzyme. J Biochem (Tokyo) 131:383-389.
14. Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, Canzian F, Tommasino M. 2006. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 44:2025-2031.
15. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa, Clemens SA, Dubin G. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 367: 1247-1255.
16. Hassen E, Chaieb A, Letaief M, Khairi H, Zakhama A, Remadi S, Chouchane L. 2003. Cervical human papillomavirus infection in Tunisian women. Infection 31:143-148.
17. Hong TC, Mai QL, Cuong DV, Parida M, Minekawa H, Notomi T, Hasebe F, Morita K. 2004. Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 42:1956-1961.
18. Inoue M, Sakaguchi J, Sasagawa T, Tango M. 2006. The evaluation of humapapillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. Int J Gynecol Cancer 16: 1007-1013.
19. Ishi K, Suzuki F, Saito A, Kubota T. 2000. Prevalence of human papillomavirus, Chlamydia trachomatis, and Neisseria gonorrhoeae in commercial sex workers in Japan. Infect Dis Obstet Gynecol 8:235-239.
20. Kondo K, Ishii Y, Ochi H, Matsumoto T, Yoshikawa H, Kanda T. 2007. Neutralization of HPV16, 18, 31 and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology 20:266-272.
21. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645-1651.
22. Lin H, Ma YY, Moh JS, Ou YC, Shen SY, ChangChien CC. 2006. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 101:40-45.
23. Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, Krunfly C, van den Brule AJ, Meijer CJ, Muñoz N, Herrero R. 2003. Prevalence of human papillomavirus infection among women in Concordia, Argentina: A population-based study. Sex Transm Dis 30:593-599.
24. Matsukura T, Sugase M. 2004. Human papillomavirus genomes in squamous cell carcinomas of the uterine cervix. Virology 324:439-449.
25. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
26. Ndembi N, Habakkuk Y, Takehisa J, Takemura T, Kobayashi E, Ngansop C, Songok E, Miura T, Ido E, Hayami M, Kaptue L, Ichimura H. 2003. HIV type 1 infection in Pygmy hunter gatherers is from contact with Bantu rather than from nonhuman primates. AIDS Res Hum Retroviruses 19:435-439.
27. Ngelangel C, Muñoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJ, Walboomers JM. 1998. Causes of cervical cancer in the Philippines: A case-control study. J Natl Cancer Inst 90:43-49.
28. Ortiz M, Torres M, Muñoz L, Fernández-García E, Canals J, Cabornero AI, Aguilar E, Ballesteros J, Del Amo J, García-Sáiz A. 2006. Oncogenic human papillomavirus (HPV) type distribution and HPV type 16E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 44:1428-1434.
29. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
30. Perrons C, Kleter B, Jelley R, Jalal H, Quint W, Tedder R. 2002. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic. J Med Virol 67:246-252.
31. Poon LL, Wong BW, Chan KH, Ng SS, Yuen KY, Guan Y, Peiris JS. 2005. Evaluation of real-time reverse transcriptase PCR and real-time loop-mediated amplification assays for severe acute respiratory syndrome coronavirus detection. J Clin Microbiol 43:3457-3459.
32. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. 1997. PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35: 1304-1310.
33. Sasagawa T, Basha W, Yamazaki H, Inoue M. 2001. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10:45-52.
34. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle PE, Burk RD. 2005. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337:76-84.
35. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr., Young N. 2002. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. J Am Med Assoc 287:2114-2119.
36. Tideman RL, Thompson C, Rose B, Gilmour S, Marks C, van Beek I, Berry G, O'Connor C, Mindel A. 2003. Cervical human papillomavirus infections in commercial sex workers-risk factors and behaviours. Int J STD AIDS 14:840-847.
37. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779-787.
38. Wheeler CM. 2007. Advances in primary and secondary interventions for cervical cancer: Human papillomavirus prophylactic vaccines and testing. Nat Clin Pract Oncol 4:224-235.
39. Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M, Nakitare GW, Ichimura H, Inoue M. 2008. Human papillomavirus infection and cervical abnormality in Nairobi, Kenya, an area with high prevalence of human immunodeficiency virus infection. J Med Virol 80:847-855.